Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (141-150 of 939) with videos related to

Pageof 94
Sort By:
Cancer Research|July 23, 1999
Castration-induced apoptosis of androgen-dependent shionogi carcinoma is associated with increased expression of genes encoding insulin-like growth factor-binding proteinsT Nickerson, H Miyake, M E Gleave, et al.
Expert Review of Anticancer Therapy|December 13, 2005
Antisense oligodeoxynucleotide therapy for bladder cancer: recent advances and future prospectsHideaki Miyake, Isao Hara, Masato Fujisaw, et al.
Current Urology Reports|January 24, 2007
Therapeutic options in advanced prostate cancer: present and futureRichard D Sowery, Alan I So, Martin E Gleave
Cancer Causes & Control : CCC|September 27, 2005
Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysisMahyar Etminan, J Mark FitzGerald, Martin Gleave, et al.
Oncotarget|February 13, 2025
Correction: Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progressionHaolong Li, Ning Xie, Martin E Gleave, et al.
British Journal of Cancer|December 3, 2024
Editorial Expression of Concern: Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma modelY Kususda, H Miyake, M E Gleave, et al.
Journal of General Microbiology|January 1, 1992
Identification of an insecticidal crystal protein from Bacillus thuringiensis DSIR517 with significant sequence differences from previously described toxinsA P Gleave, R J Hedges, A H Broadwell
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 11, 2013
The future of systemic therapies for localised prostate cancerB J Eigl, M E Gleave, K N Chi
Proceedings of the Royal Society of Medicine|December 9, 2009
Drilling of the Osteoarthritic HipJ Agerholm-Christensen, D M Copenhagen, J R Gleave
Cancer Metastasis Reviews|October 29, 2002
Antisense therapy: current status in prostate cancer and other malignanciesMartin Gleave, Hideake Miyake, Uwe Zangemeister-Wittke, et al.
Pageof 94

Showing results (141-150 of 939) with videos related to

Sort By:
Pageof 94
Cancer Research|July 23, 1999
Castration-induced apoptosis of androgen-dependent shionogi carcinoma is associated with increased expression of genes encoding insulin-like growth factor-binding proteinsT Nickerson, H Miyake, M E Gleave, et al.
Expert Review of Anticancer Therapy|December 13, 2005
Antisense oligodeoxynucleotide therapy for bladder cancer: recent advances and future prospectsHideaki Miyake, Isao Hara, Masato Fujisaw, et al.
Current Urology Reports|January 24, 2007
Therapeutic options in advanced prostate cancer: present and futureRichard D Sowery, Alan I So, Martin E Gleave
Cancer Causes & Control : CCC|September 27, 2005
Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysisMahyar Etminan, J Mark FitzGerald, Martin Gleave, et al.
Oncotarget|February 13, 2025
Correction: Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progressionHaolong Li, Ning Xie, Martin E Gleave, et al.
British Journal of Cancer|December 3, 2024
Editorial Expression of Concern: Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma modelY Kususda, H Miyake, M E Gleave, et al.
Journal of General Microbiology|January 1, 1992
Identification of an insecticidal crystal protein from Bacillus thuringiensis DSIR517 with significant sequence differences from previously described toxinsA P Gleave, R J Hedges, A H Broadwell
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 11, 2013
The future of systemic therapies for localised prostate cancerB J Eigl, M E Gleave, K N Chi
Proceedings of the Royal Society of Medicine|December 9, 2009
Drilling of the Osteoarthritic HipJ Agerholm-Christensen, D M Copenhagen, J R Gleave
Cancer Metastasis Reviews|October 29, 2002
Antisense therapy: current status in prostate cancer and other malignanciesMartin Gleave, Hideake Miyake, Uwe Zangemeister-Wittke, et al.
Pageof 94